Betta Pharmaceuticals Co (SZSE:300558) Days Sales Outstanding : 30.62 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Days Sales Outstanding?

Betta Pharmaceuticals Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥247 Mil. Betta Pharmaceuticals Co's Revenue for the three months ended in Mar. 2024 was ¥736 Mil. Hence, Betta Pharmaceuticals Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 30.62.

The historical rank and industry rank for Betta Pharmaceuticals Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300558' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.18 Med: 16.04 Max: 53.48
Current: 50.77

During the past 13 years, Betta Pharmaceuticals Co's highest Days Sales Outstanding was 53.48. The lowest was 6.18. And the median was 16.04.

SZSE:300558's Days Sales Outstanding is ranked better than
70.38% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs SZSE:300558: 50.77

Betta Pharmaceuticals Co's Days Sales Outstanding declined from Mar. 2023 (67.24) to Mar. 2024 (30.62).

Betta Pharmaceuticals Co Days Sales Outstanding Historical Data

The historical data trend for Betta Pharmaceuticals Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Days Sales Outstanding Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

14.07

10.60

18.00

46.25

53.48

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															67.24	49.58	62.91	87.64	30.62

Competitive Comparison of Betta Pharmaceuticals Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Betta Pharmaceuticals Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Days Sales Outstanding falls into.

Betta Pharmaceuticals Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Betta Pharmaceuticals Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (433.314	+	286.41)	/	2 )	/	2456.196	*	365
=	359.862					/	2456.196	*	365
=	53.48

Betta Pharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (286.41	+	207.417)	/	2 )	/	735.775	*	365 / 4
=	246.9135					/	735.775	*	365 / 4
=	30.62

Betta Pharmaceuticals Co (SZSE:300558) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Betta Pharmaceuticals Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Executives

Wang Jia Bing	Directors, executives
Ding Lie Ming	Directors, executives
Cai Wan Yu	Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines